Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:39 PM
Ignite Modification Date:
2025-12-26 @ 2:39 PM
NCT ID:
NCT05679206
Eligibility Criteria:
Inclusion Criteria:
* Age: \> 16 years.
* Consent or waiver of consent according Chapter 9
* Preeclampsia
Defined as:
• New onset hypertension (blood pressure \>140/90mmHg on multiple occasions after 20 weeks of gestation)
In combination with new onset of 1 or more of the following:
* Proteinuria (urine protein \>300mg /24h or 2+ or higher in dipstick on multiple occasions)
* Platelet count \<100,000/microL,
* Serum creatinine \>97.2 micromol/L,
* Liver transaminases at least twice the upper limit of the normal concentrations,
* Pulmonary edema,
* New-onset and persistent headache,
* Visual symptoms. -Postnatal follow up at the obstetrical and cardiology clinic, Inselspital Bern, Switzerland.
Exclusion Criteria:
* Age: \< 16 years
* Incomplete or ambiguous data: if data confirming the eligibility criteria or data to analyze the primary endpoint is not fully available or despite efforts assessed as significantly ambiguous, the data set will be excluded from analyses, since no analysis is possible
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
16 Years
Study:
NCT05679206
Study Brief:
Protocol Section:
NCT05679206